At a Glance
| Fadogia Agrestis | Magnesium Glycinate | |
|---|---|---|
| Class | Supplement | Supplement |
| Common Dose (oral) | 300–600 mg | 200–350 mg |
| Total Duration | 5–11 hrs | 3–6.5 hrs |
| Routes | Oral | Oral |
Fadogia Agrestis, a Supplement, and Magnesium Glycinate, a Supplement, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Supplements, meaning they share a common pharmacological foundation. They share 2 documented effects in common, with 5 effects unique to Fadogia Agrestis and 6 unique to Magnesium Glycinate. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Fadogia Agrestis | Magnesium Glycinate | |
|---|---|---|
| Class | Supplement | Supplement |
| Common Dose (oral) | 300–600 mg | 200–350 mg |
| Total Duration | 5–11 hrs | 3–6.5 hrs |
| Routes | Oral | Oral |
| Effects |
| 7 documented |
| 8 documented |
| Level | Fadogia Agrestis | Magnesium Glycinate |
|---|---|---|
| Threshold | 100 mg | 50 mg |
| Light | 200–300 mg | 100–150 mg |
| Common | 300–600 mg | 200–350 mg |
| Strong | 600–1000 mg | 350–500 mg |
| Heavy | 1000 mg | 500 mg |
Fadogia Agrestis
Magnesium Glycinate
No direct interaction data available between these substances. This does not mean the combination is safe.
No dangerous interactions recorded.
No dangerous interactions recorded.